tazarotene is a Topical Aerosol, Foam in the Human Prescription Drug category. It is labeled and distributed by Mayne Pharma Inc.. The primary component is Tazarotene.
| Product ID | 68308-685_451596c3-6559-45f8-aab7-9c682b85e8c8 |
| NDC | 68308-685 |
| Product Type | Human Prescription Drug |
| Proprietary Name | tazarotene |
| Generic Name | Tazarotene |
| Dosage Form | Aerosol, Foam |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2021-04-23 |
| Marketing Category | NDA AUTHORIZED GENERIC / |
| Application Number | NDA202428 |
| Labeler Name | Mayne Pharma Inc. |
| Substance Name | TAZAROTENE |
| Active Ingredient Strength | 1 mg/g |
| Pharm Classes | Retinoid [EPC],Retinoids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-04-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0168-0454 | TAZAROTENE | tazarotene |
| 0713-0670 | Tazarotene | Tazarotene |
| 0713-0764 | Tazarotene | Tazarotene |
| 0713-0804 | TAZAROTENE | tazarotene |
| 0713-0805 | TAZAROTENE | tazarotene |
| 51672-1373 | Tazarotene | Tazarotene |
| 51672-1374 | Tazarotene | Tazarotene |
| 60758-556 | Tazarotene | Tazarotene |
| 60758-561 | Tazarotene | Tazarotene |
| 68308-685 | tazarotene | tazarotene |
| 68308-745 | Tazarotene | TAZAROTENE |
| 0187-2098 | Arazlo | tazarotene |
| 0023-9236 | AVAGE | tazarotene |
| 51862-295 | FABIOR | tazarotene |
| 0168-0455 | Tazarotene Cream | tazarotene |
| 0023-0042 | TAZORAC | tazarotene |
| 0023-8335 | TAZORAC | tazarotene |
| 0023-9155 | TAZORAC | tazarotene |
| 0023-9156 | TAZORAC | tazarotene |
| 16110-042 | Tazorac | tazarotene |
| 16110-833 | Tazorac | tazarotene |
| 16110-915 | TAZORAC | tazarotene |
| 16110-916 | TAZORAC | tazarotene |